The Short-term Effect of Low-load Resistance Training with Blood-flow Restriction on Somatosensory-evoked Potentials in Healthy Young Adults
Launched by UNIVERSITY OF SHARJAH · Jan 1, 2025
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific type of exercise called low-load resistance training with blood flow restriction (BFRT) on how our bodies process sensory information. Researchers want to understand if this training can change how our brains respond to sensory signals, which might be reflected in measurements called somatosensory-evoked potentials (SSEPs). They will also look at how different widths of the cuffs used in the training affect both the sensory processing and the level of pain participants feel during the exercise.
To participate in this trial, you need to be a healthy adult between the ages of 18 and 30, without a history of heart or joint problems, and with a body mass index (BMI) under 25. Participants will take part in three separate training sessions spaced three days apart, where they will perform the exercises while wearing a cuff that restricts blood flow. The trial is not yet recruiting, but it's important to know that anyone with certain health issues, like a history of blood clots or neurological diseases, won't be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants will be included if they are aged 18-30 years of both genders, with no history of cardiovascular problems or osteo-articular problems in the lower limbs, and if they responded negatively to all items of the Physical Activity Readiness Questionnaire (PAR-Q).
- • Participants will be included if they have a body mass index (BMI) less than 25 or non-overweight individuals.
- • Use of the long international physical activity questionnaire (L-IPAQ) to ensure all participants have equal physical activity levels.
- Exclusion Criteria:
- • Participants will be excluded if they did not meet the inclusion criteria, and if they had a history of deep vein thrombosis (DVT), congenital heart disease, varicose veins, currently pregnant, or any contraindications to exercise.
- • Participants will be excluded if they were diagnosed with any neurological disease.
- • Participants will be excluded if they have had any musculoskeletal injury in the past 3 months to avoid potential effect on their physical activity levels.
About University Of Sharjah
The University of Sharjah, a leading academic institution in the United Arab Emirates, is dedicated to advancing healthcare through innovative research and education. With a robust commitment to clinical excellence, the university actively sponsors clinical trials that aim to address pressing health challenges and improve patient outcomes. Leveraging state-of-the-art facilities and a multidisciplinary team of experts, the University of Sharjah fosters a collaborative environment that enhances the quality and impact of its research initiatives, ultimately contributing to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sharjah, United Arab Emirates
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported